Related by context. All words. (Click for frequent words.) 73 Poster Presentations 72 Late Breaker 71 Oral Presentation 71 Oral Presentations 70 Poster Discussion 68 Double Blind Placebo 68 AASLD Meeting 68 ACR ARHP 67 Phase Ib Clinical Trial 67 Acute Heart Failure 67 Refractory Angina 67 Oral Fingolimod 67 Clinical Trial Results 66 Antiviral Therapy 66 Lung Cancer Trial 66 Coronary Revascularization 66 Preclinical Data 66 Clinical Trial Data 66 Pooled Analysis 66 Breast Ultrasound 65 Annual ICAAC 65 Therapeutic Targets 65 Anticancer Drug 65 Suppl. 65 Peer Reviewed Journal 65 Cell Transplant 65 Preclinical Study 65 Poster Presentation 65 Proc Am Soc 65 Phase 2b Clinical Trial 65 Treatment Regimens 65 Novel Approaches 64 SABCS 64 Nicotine Vaccine 64 Phase 2a Clinical Trial 64 ICAAC IDSA 64 Controlled Study 64 Systemic Sclerosis 64 Phase 2b Trial 64 HCV Protease Inhibitor 64 Differential Diagnosis 64 OR Live.com Presents 64 Anticancer Drugs 64 Prospective Multicenter 64 Breast Brachytherapy 64 Myoblast 64 Phase 2a Trial 64 Study Evaluating 64 See CLINICAL PHARMACOLOGY 64 ASCO Breast Cancer 64 Antiplatelet Therapy 64 Neoplasia 64 Confirmatory Phase 64 Initiated Phase 64 Largest Database 64 Randomized Clinical Trial 64 Hernia Repair 64 ANN INTERN MED 63 Novel Inhibitor 63 Selective Cardiac Myosin Activator 63 Adjuvant Chemotherapy 63 Osteoporosis Treatment 63 Stent Thrombosis 63 Renal Cancer 63 Prolongs Survival 63 Hormone Refractory Prostate Cancer 63 Abstract Number 63 Patient Enrollment 63 Treating Chronic 63 Selective Cardiac Myosin 63 ASCO GI 63 Uterine Fibroid Embolization 63 Phase 2b Study 63 Meets Primary Endpoint 63 Clinical Outcome 63 Oral Insulin Capsule 63 Surgical Treatment 63 Phase III Clinical Trial 63 ASBMR 63 Prospective Randomized 63 Submission Deadline 63 Vaccine Adjuvants 62 Controlled Trial 62 Dose Ranging Study 62 UEGW 62 AAEP Convention 62 entitled Synergistic 62 Demonstrates Efficacy 62 Biological Therapy 62 Brain Metastases 62 Urinary Incontinence 62 Neoadjuvant Chemotherapy 62 ASH Annual Meeting 62 Drug Eluting 62 Antiviral Activity 62 Kidney Transplant Patients 62 Inflammatory Arthritis 62 Anticancer Activity 62 Hematological Malignancies 62 Protein Synthesis 62 Study Shows Benefits 62 Multicenter Phase 62 abstr 62 Clinical Efficacy 62 Therapeutic Approaches 62 Aneurysm Repair 62 ECCMID 62 Total Knee Arthroplasty 62 Cardiotoxicity 62 Nuvelo Announces 62 Randomized Phase III 62 HDAC Inhibitor 62 S#.# [006] 62 Metastatic Melanoma 62 First Patient Enrolled 62 Phase 1b Clinical Trial 62 Announces Poster Presentations 62 Heart Failure Patients 62 Randomized Trials 62 Sleep Disturbances 62 Treated Patients 62 Investigational Drug 62 Abstract Accepted 62 Treatment Algorithm 62 Adjuvant Breast Cancer 62 Prostate Screening 62 Compression Fractures 62 USpella 62 Pharmacy OneSource Announces 62 Proves Successful 62 Respiratory Distress 62 Cervical Spine 62 Biomarker Study 62 Dose Ranging 62 Vulnerable Plaque 62 Surgical Mesh 62 II Clinical Trial 61 Tyrosine Kinase Inhibitor 61 Guidelines Recommend 61 Tumor Microenvironment 61 Improving Patient Safety 61 Artery Disease 61 Minimally Invasive Treatment 61 IND Filing 61 Molecular Basis 61 Slows Progression 61 Placebo Controlled Study 61 Multicenter 61 Stent Placement 61 Phase IIa Clinical Trial 61 Preclinical Models 61 Zix Corporation Announces 61 Investigational Treatment 61 Mouse Models 61 Hsp# Inhibitor 61 Soft Tissue Sarcoma 61 Novel Antibiotic 61 CALL FOR ENTRIES 61 Randomized Clinical Trials 61 Liver Tumors 61 Transdermal Patch 61 Heart Transplant Recipients 61 Dose Escalation 61 Novel Oral 61 Appears Safe 61 Clinical Trial Evaluating 61 Lung Cancer Treatment 61 Patients Treated With 61 Combination REOLYSIN R 61 ST Segment Elevation 61 Acute Ischemic Stroke 61 #nd Annual Meeting 61 Relapsing Multiple Sclerosis 61 Immune Mediated 61 Intravenous Formulation 61 FDA Approvals 61 Hepatocellular Carcinoma 61 Shows Promise Against 61 Clin Oncol 61 Arterial Disease 61 Advanced Renal Cell 61 HFSA Annual 61 Drug Candidate 61 REMINDER ORLive Presents 61 Coronary Arteries 61 Activator CK # 61 Renal Function 61 Completes Patient Enrollment 61 First Patient Dosed 61 Non Invasive Treatment 61 Phase IIb Trial 61 Hepatitis C Treatment 61 Curr Opin 61 ASCO GU 61 Eur J 61 Transdermal Delivery 61 Oral Cavity 61 Key Milestones 61 Dendritic Cells 61 AACR San Antonio 61 TenFold Announces 61 Treatment Regimen 61 Pivotal Clinical Trial 61 Mouse Model 61 Carotid Endarterectomy 61 Elagolix 61 Migraine Drug 61 #-# Full Text 61 Randomized Phase 61 Initiate Phase 61 Therapeutics TCT scientific 61 Educational Webinar 61 Advanced Melanoma 61 IND Application 61 Emerging Therapies 61 Tezampanel 61 Schizophrenia Treatment 61 Cardiovascular Disease Risk 61 Castration Resistant Prostate Cancer 61 Delcath Phase III 61 Antitumor Activity 61 Carotid Stenting 61 Fungal Infections 61 Therapeutics TCT 61 Preclinical Evaluation 61 Phase IIb Clinical Trial 60 Phase III Pivotal Trial 60 Endovascular Repair 60 Catheter Ablation 60 Trial Evaluating 60 Low Incidence 60 Molecular Mechanisms 60 Randomized Double Blind Placebo 60 Randomized Double Blind 60 Novel Therapeutic 60 Diabetic Neuropathy 60 Blood Cancers 60 Breast Cancer Recurrence 60 Breast Carcinoma 60 Adjunctive Therapy 60 Multiple Myeloma Patients 60 Systemic Delivery 60 Kidney Function 60 CyberKnife Radiosurgery 60 Prostate Cancer Vaccine 60 Parenteral Nutrition 60 Cardiostim 60 M.D. Ph.D. 60 Obstet Gynecol 60 Dose Reduction 60 lexidronam injection 60 Shows Efficacy 60 Neurosurg 60 Laryngeal Cancer 60 Oral Session 60 Guidelines Issued 60 Single Dose 60 FDA Okays 60 Improve Diagnosis 60 Tissue Engineered 60 ASGT 60 Content Outline 60 Novel Therapeutics 60 Subgroup Analysis 60 Phase III Trial 60 ASGCT 60 Postdoctoral Position 60 Overactive Bladder 60 J Pediatr 60 Valvular Heart Disease 60 Pivotal Study 60 Oral Mucositis 60 Sustained Efficacy 60 Orally Active 60 Clinical Trials Update 60 JAK2 Inhibitor 60 Presents Preclinical Data 60 Pharmacodynamics 60 Vitro Activity 60 Periodontal Disease 60 Improved Survival 60 Ocular Inflammation 60 Drug Shows Promise 60 Patient Enrolment 60 Demonstrates Significant 60 Treating Depression 60 Patient Outcomes 60 ASCO Annual Meeting 60 Reduce Mortality 60 Gentium Announces 60 AACR Meeting 60 Female Urology 60 Anti Tumor Activity 60 Aggressive Reduction 60 Adenoma 60 Rotavirus Vaccine 60 Ovarian Cancer Patients 60 Crit Rev 60 Improves Outcomes 60 Oral Insulin 60 Randomised Controlled Trial 60 Midatlantic Employers Association 60 Diabetic Nephropathy 60 Histone Deacetylase 60 Kinase Inhibitor 60 Rheumatol 60 SUO 60 Acute Decompensated Heart Failure 60 Diabetic Foot Ulcer 60 Breaking Clinical Trials 60 Molecular Pathogenesis 60 Randomized Double blind 60 Liver Failure 60 Disease Modifying 60 Rheumatology ACR Annual 60 Zenvia Phase III 60 Device Helps 60 Coronary Artery Calcium 60 Venous Thromboembolism 60 Optical Coherence Tomography 60 Orthostatic Hypotension 60 Successfully Completes Phase 60 J Clin 60 Therapeutic Advances 60 Newly Diagnosed Breast Cancer 60 ISTODAX ® 60 Clinical Evaluation 60 Cancer Stem Cells 60 Pivotal Phase II 60 IN PATIENTS WITH 60 Autoimmune Diseases 60 Aortic Dissection 60 Less Invasive 60 Antiplatelet 60 Therapy Shows Promise 60 Files IND 60 Anti CD# Antibody 60 #:# -# [003] 60 Potent Antiviral Activity 60 Renal Cell Carcinoma 59 Image Guided 59 Topline Results 59 Granted Orphan Drug 59 Bipolar Disorders 59 Investigational Agent 59 Hematological 59 Therapeutic Vaccines 59 Highly Selective 59 Gastric Cancer 59 Diamyd Medical Diamyd 59 Glufosfamide 59 HER2 Positive 59 Genetic Markers 59 Free Full Text 59 Annual Interscience Conference 59 FASEB J. 59 Stent Implantation 59 Endometrial Cancer 59 Arch Neurol 59 Autoimmune Disease 59 Neovascularization 59 VEITHsymposium 59 Pharmaceuticals Initiates 59 Prenatal Diagnosis 59 Knee Osteoarthritis 59 Valopicitabine NM# 59 Improves Survival 59 Small Molecule 59 Nat Genet 59 Panel Discussions 59 Inflammatory Disease 59 Environ Health Perspect 59 Therapy Improves 59 Contrast Agent 59 Initiates Clinical Trial 59 Gynecol Oncol 59 Receives Orphan Drug Designation 59 Capsule Endoscopy 59 Patients Undergoing 59 Immunomodulatory 59 Demonstrates Sustained 59 Eluting Stent 59 Antithrombotic 59 Randomized Controlled Trials 59 Lung Cancer Survival 59 Slow Progression 59 Mimetics 59 Peripheral Vascular Disease 59 ACC.# 59 Treatment Reduces 59 Adjuvant Treatment 59 Imaging Diagnostic 59 #:#-# [001] 59 Relapsed Multiple Myeloma 59 Ann Rheum Dis 59 Metastatic Renal Cell Carcinoma 59 Glatiramer Acetate 59 Sangamo BioSciences Announces 59 Minimally Invasive Spine Surgery 59 Aethlon Medical Announces 59 Breast Exams 59 Liver Metastases 59 Sirolimus Eluting Stent 59 Scientific Poster Session 59 antibody blinatumomab MT#/MEDI-# 59 BioContact Quebec 59 Seasonal Influenza Vaccine 59 Microwave Ablation System 59 Thrombolytic Therapy 59 Pharmacokinetic Study 59 Kinase Inhibitors 59 Initiates Phase III 59 Prevent Stroke 59 PRAECIS PHARMACEUTICALS INCORPORATED 59 Pivotal Trial 59 LENALIDOMIDE 59 Vaccine Adjuvant 59 Prognostic Value 59 J Child Adolesc 59 Brentuximab Vedotin SGN 59 Practical Aspects 59 Single Incision 59 Gene Silencing 59 Prognostic Factors 59 Neuroendocrine Tumors 59 Treating Heart Failure 59 CT Angiography 59 PMID # [001] 59 Lung Cancer Drug 59 Preclinical Efficacy 59 Kidney Transplant Recipients 59 AACR #st Annual Meeting 59 Dose Response 59 Skin Lesions 59 Keystone Symposium 59 HCV Genotype 59 Immunomedics Announces 59 Pulmonary Artery 59 STENT 59 Beneficial Effects 59 Myelodysplastic Syndromes 59 Acute Renal Failure 59 Prostate Cancer Treatment 59 Bone Metastases 59 Uterine Cancer 59 Demonstrates Potential 59 Contrast Agents 59 Safety Tolerability 59 FINAL RESULTS 59 Partial Nephrectomy 59 ExL Pharma 59 HIMSS# Interoperability Showcase 59 Brain Scans 59 Diabetic Foot Care 59 Efficacy Endpoints 59 Localized Prostate Cancer 59 Pivotal Phase III 59 Smooth Muscle 59 Multicentre 59 Targeted Therapy 59 Epithelium 59 Initiate Phase III 59 First Trimester 59 doi #.# 59 Therapeutic Vaccine 59 MITTEILUNG UEBERMITTELT VON BUSINESS 59 Cinacalcet 59 Sirolimus eluting 59 Annual Transcatheter Cardiovascular 59 Comorbidities 59 Long Term Outcomes 59 Novel Compound 59 #st Annual Meeting 59 Outpatient Setting 59 Non Inferiority 59 Phase III Clinical Trials 59 Patients Receiving 59 Prognostic Significance 59 Left Ventricular 59 Survival Benefit 59 DermTech International 59 Patients Suffering 59 Present Preclinical Data 59 Antiviral Agents 59 Completes Enrollment 59 Tuberculosis Vaccine 59 Carotid 59 Improve Survival 59 Imaging Techniques 59 NPS Pharmaceuticals Announces 58 Pharmacyclics Announces 58 Recurrent Prostate Cancer 58 ENDO 58 Clinical Decision Making 58 CROI 58 AACR NCI EORTC 58 Cambridge Healthtech Institute 58 Solid Tumors 58 Randomized Controlled 58 Demonstrates Positive 58 Innate Immunity 58 Hedgehog Pathway Inhibitor 58 ARRY # 58 Surgical Procedures 58 Proves Effective 58 WorldHeart Announces 58 transthyretin TTR mediated amyloidosis 58 Antigen Specific 58 Clin Infect Dis 58 PHASE III 58 Myeloma Patients 58 Interferon Gamma 58 Pediatric Patients 58 Patient Treated 58 Central Retinal Vein 58 Therapeutic Potential 58 Genetic Basis 58 Crit Care 58 doi #.#/fj.#-# 58 Percutaneous Tibial Nerve Stimulation 58 Randomized Placebo controlled 58 Safinamide 58 Menstrual Pain 58 Combination Treatment 58 Statistically Significant 58 #:# -# [005] 58 Drug Eluting Stents 58 Mitochondrial Dysfunction 58 Thrombotic 58 Initiates Enrollment 58 Breakout Sessions 58 Adjunctive Treatment 58 Cancer Immunotherapy 58 SA FC# 58 Epeius Biotechnologies Corporation 58 Male Infertility 58 Protease Inhibitors 58 Chronic Rhinosinusitis 58 Early Diagnosis 58 Inflammatory Markers 58 Tigecycline 58 Initiates Phase 2b 58 Drug Combo 58 EuroIntervention 58 Gastrointestinal Cancers Symposium 58 Limb Ischemia 58 Mammalian Cells 58 Lumbar Spine 58 PHASE II 58 Fifteenth Annual 58 Molecular Medicine Tri 58 GATTEX TM 58 Susceptibility Gene 58 Inuit Sculpture 58 Digestive Tract 58 Cancer Vaccines 58 Fecal Incontinence 58 ONGLYZA TM 58 Placebo Controlled Trial 58 Bazedoxifene 58 Diagnostic Tests 58 Patients Treated 58 Test Detects 58 Pulmonary Arterial Hypertension 58 Arch Facial Plast 58 Drug Eluting Coronary Stent 58 #:# -# [001] 58 Decitabine 58 Scand J 58 Observational Study 58 Metastatic Prostate Cancer 58 FDA Approves Drug 58 #th Interscience Conference 58 Trodusquemine MSI 58 #:#-#,# [003] 58 Antibacterial Drug 58 Initiates Clinical Trials 58 Topical Treatment 58 Pressure Ulcer Prevention 58 Protease Inhibitor 58 Critically Ill Patients 58 Node Positive 58 Abstract Full Text 58 VIVUS Announces 58 Nephropathy 58 Cytotoxicity 58 Intravascular 58 BREEDERS CROWN 58 PLENARY 58 Menopausal Symptoms 58 Protein Linked 58 Inflammatory Diseases 58 Stent Restenosis 58 Contains Detailed 58 Egg Freezing 58 Novel Therapies 58 Pulmonary Vein Isolation 58 Upcoming Investor 58 ISPOR 58 Lung Tumors 58 Often Misdiagnosed 58 Subtypes 58 R roscovitine 58 Chronic Hepatitis B 58 AACR IASLC Joint 58 Molecular Diagnostic Test 58 Lupus Drug 58 Trigeminal Neuralgia 58 Inflammatory Bowel Diseases 58 Ophthalmol 58 Progenitor Cells 58 Migraine Treatment 58 Pre Cancerous 58 Phase 2a Study 58 Injection Site 58 Colorectal Cancer Patients 58 Malignant Lymphoma 58 ORLive Presents 58 J Nutr 58 Embolic Protection 58 Long Term Efficacy 58 Semafore Pharmaceuticals 58 RNAi Therapeutic 58 Chronic Wounds 58 Initiates Phase II 58 Osteoporosis Screening 58 Meta Analysis 58 Inhaled Corticosteroids 58 Lens Implant 58 Ultrasound Imaging 58 Int J Epidemiol 58 Aflibercept 58 Erectile Dysfunction Drug 58 Proteasome 58 Vertebral Fractures 58 Cardiac Arrhythmias 58 Surgical Technique 58 Coronary Intervention 58 Society CTOS 58 BioPartnering Europe 58 Cognitive Impairment 58 Breast Tissue 58 Rheumatoid 58 J Virol 58 Renal Cell Cancer 58 Oral Abstract 58 Patency 58 Pregnancy Outcomes 58 Ovarian Cancer Treatment 58 Kidney Transplants 58 Previously Treated 58 Chronic Sinusitis 58 Clavis Pharma ASA 58 Innovative Approaches 58 Prophylactic Treatment 58 Molecular Origins 58 Recurrent Breast Cancer 58 Mycophenolate Mofetil 58 Renal Failure 58 Osteoarthritis Pain 58 Novel Mechanism 58 Genes Linked 58 Drug Eluting Balloon 58 Breast Density 58 Bare Metal Stent 58 HER2 Positive Breast Cancer 58 Telik Announces 58 CABG Surgery 58 Oral Cladribine 58 Parathyroid Hormone 58 Effectively Treats 58 Valve Replacement 58 Imaging Technique 58 ASCO Abstract 58 Randomized Study 58 Interv 58 Multicenter Trial 58 Fast Skeletal Troponin 58 Rotator Cuff Repair 58 Cardiovasc 58 Plaque Psoriasis 58 Sapacitabine 57 Radiation Dose 57 Transplant Patients 57 #:#-# [030] 57 Pelvic Organ Prolapse 57 Chronic Heart Failure 57 Anti Tumor 57 Keynote Speakers Announced 57 Prostate Cancer Screening 57 Gene Linked 57 Proven Effective 57 Peripheral Blood 57 Total Hip Replacement 57 Confirms Efficacy 57 Multimodality 57 fosbretabulin 57 Infarct 57 BIOLASE Announces 57 Endarterectomy 57 Radiation Induced 57 #:#-# [033] 57 Eye Diseases 57 Helps Predict 57 Colorectal Screening 57 Induction Chemotherapy 57 Speakers Announced 57 Clin Pharmacol Ther 57 Severe Sepsis 57 Pemphigus Vulgaris 57 Invasive Breast Cancer 57 Hemodialysis Patients 57 Antiangiogenic 57 Solid Malignancies 57 Alternative Treatments 57 Immunotherapeutic 57 Pivotal Phase 57 JAK Inhibitor 57 Files Investigational 57 Interventional Oncology 57 Nat Rev 57 'S SCHEDULE 57 Renal Anemia 57 Long Term Survival 57 Multiple Ascending Dose 57 SYN# 57 Gene Variants 57 Connective Tissue Oncology 57 Beta Blocker 57 FDA Accepts 57 Islet Transplantation 57 Lung Infections 57 Schizophrenia Bulletin 57 Quadrivalent 57 suppl. 57 Surgical Techniques 57 Antibiotic Treatment 57 Obese Teens 57 Severe Asthma 57 GLOSSARY OF 57 Nineteenth Annual 57 Announces Rescheduling 57 Clinical Documentation 57 Tesetaxel 57 Stem Cell Treatment 57 StockProfit.com Small Cap 57 Radiofrequency Ablation 57 Unresectable 57 ECTRIMS 57 Advanced Colorectal Cancer 57 J Clin Endocrinol Metab 57 Estrogen Therapy 57 RECORD1 57 Biologic Therapy 57 Total Knee Replacement 57 Ischemic Stroke 57 Antitumor 57 #:#-# [019] 57 Double Blind Randomized 57 Help Diagnose 57 #:#-#,# [002] 57 Osteoarthritis Patients 57 Hematological Cancers 57 Pediatric Pulmonology 57 Clostridium difficile Infection 57 Lupus Nephritis 57 Placebo Controlled 57 Practice Guideline 57 Endoluminal 57 Announce Collaboration Agreement 57 Novel Approach 57 Ocular Diseases 57 J Am Coll 57 Irbesartan 57 Liposomal 57 Current Controlled Trials 57 Drugs Affecting Lipid 57 Multicenter Study 57 APRICOT 57 Statin Therapy 57 Investigational Compound 57 ID NCT# 57 Keynote Lineup 57 Chronic Lymphocytic Leukemia 57 Symptom Relief 57 Genetic Variations 57 Hematologic Malignancies 57 Aptamer 57 Gout Drug 57 Hypertensive Patients 57 J Shoulder Elbow 57 Blocked Arteries 57 Stem Cell Differentiation 57 Drug Formulation 57 Ultrasound Guided 57 Oligonucleotides 57 Hepatitis B Vaccine 57 Epidemiol 57 Antiepileptic Drug 57 Intra Arterial 57 Patients Enrolled 57 Lowers Risk 57 Technological Innovations 57 Psychological Effects 57 ASTRO Annual Meeting 57 Preterm Labor 57 Oral Anticoagulant 57 Diabet Med 57 Neural Stem Cells 57 Now Accepting Submissions 57 Threshold Pharmaceuticals Announces 57 Prostate Disease 57 Drug Fails 57 Diabetic Foot 57 Synthetic Peptide 57 Cardiac Rhythm 57 Dupuytren Contracture 57 LibiGel ® 57 Malignant Melanoma 57 Advanced Solid Tumors 57 Celgosivir 57 Innate Immune 57 EFNS 57 Risk Stratification 57 Venous Thrombosis 57 Dual Antiplatelet Therapy 57 Polymorphism 57 iSBTc 57 Prostate Cancer Survival 57 Cardiovascular Outcomes 57 Arch Dis Child 57 Hepatic Encephalopathy 57 Immunodeficiency 57 Adjuvant Therapy 57 CLARITY study 57 Stem Cell Treatments 57 Premature Infants 57 Diabetic Macular Edema DME 57 Aurora Kinase 57 Malignant Mesothelioma 57 Diastolic Heart Failure 57 Plus Ribavirin 57 Oral Spray 57 Multicenter Randomized 57 Genes Involved 57 Intravitreal 57 ASM Biodefense 57 Spectrum Pharmaceuticals Announces 57 Ophthalmic Drugs Advisory 57 HIV Integrase 57 Lung Cancers 57 Endothelial Function 57 Windhover Therapeutic Area 57 Novel Compounds 57 Urinary Catheter 57 Endocrine Society Annual Meeting 57 Noninvasive Prenatal 57 Lifestyle Intervention 57 J Allergy Clin 57 Skeletal Muscle 57 Holds Inaugural 57 Therapy Reduces 57 Genes Predict 57 Hematopoietic Stem Cell Transplantation 57 Submits NDA 57 Collaborators Present 57 Helps Diagnose 57 Enlarged Prostate 57 CENTRAL EXCHANGE 57 Polymerase Inhibitor 57 Ablation System 57 Prostate Cancer Symposium 57 Spinal Disc 57 Genetic Variation 57 Allografts 57 AstraZeneca Targacept 57 Arch Dermatol 57 Pneumococcal Vaccine 57 Observational Studies 57 J Neurol 57 Prostate Cancer Diagnosis 57 Glucosamine Chondroitin Arthritis 57 Aeolus Pharmaceuticals Announces 57 Acute Myocardial Infarction 57 evaluating carfilzomib 57 Coronary Interventions 57 Am J Epidemiol 57 Initiates Clinical 57 Immunodeficiencies 57 Poster Session 57 Molecular Mechanism 57 Endocrinol Metab 57 Reflux Disease 57 Vaccine Protects Against 57 Prolongs Life 57 Primary Efficacy Endpoint 57 Bone Marrow Transplants 57 Rheumatoid Arthritis Patients 57 Hospitalized Patients 57 Am J Geriatr 57 Bone Marrow Stem Cells 57 Newly Diagnosed Multiple Myeloma 57 HuMax CD#b 57 PDL BioPharma Announces 57 Replacement Therapy 57 Multicenter Randomized Double 57 Intravenous Immunoglobulin 57 Demonstrates Potent 57 Phase III Pivotal 57 Osteoporosis Drug 57 Ranolazine 56 Wrinkle Treatment 56 Clinical Trial Enrollment 56 #:#-# [007] 56 nd Annual Meeting 56 Muscle Cells 56 Protein Structure 56 Cardiovascular Therapeutics 56 COVIDIEN 56 Advanced Prostate Cancer 56 Br J 56 VASCULAR 56 Related Viruses 56 Hazardous Drugs 56 Anti Inflammatory Drug 56 Aromatase Inhibitors 56 Complicated Skin 56 orally inhaled migraine 56 Significant Improvements 56 RE MODEL 56 Depressive Symptoms 56 registrational Phase 56 AATS 56 FREE SEMINAR 56 Lymph Nodes 56 PDUFA Date 56 Diabetic Ulcers 56 Cardiac Resynchronization 56 Inhaled Insulin 56 Significantly Improved 56 FDA Approvable Letter 56 FALL CLASSIC 56 Radical Prostatectomy 56 AVI BioPharma Announces 56 Malignancies 56 Int J 56 J Urol 56 Metabolic Disorder 56 Postmenopausal Hormone Therapy 56 Script Insertion Vulnerability 56 Clin J 56 Cardiopulmonary Bypass 56 Reports Preclinical Data 56 Telaprevir VX 56 Amniotic Fluid 56 #th Annual Interscience 56 CT Scanning 56 Cholesterol Lowering Drug 56 MMR Vaccine 56 Unfractionated Heparin 56 Mortality Risk 56 TECHNOLOGIST 56 Drug Prevents 56 Microfluidic Device 56 dual endothelin receptor antagonist 56 J.P. Morgan Healthcare 56 Oncol 56 Post Menopausal 56 Valopicitabine 56 Immune Cell 56 Arch Pediatr Adolesc Med 56 Diagnostic Criteria 56 Mitral Valve Repair 56 intravenous recombinant 56 #nd EORTC NCI 56 Glaucoma Treatment 56 BIO InvestorForum 56 Oncologic 56 BIO Windhover 56 Societe Internationale 56 Announcement acc 56 Ischaemic 56 Predict Risk 56 Holds Successful 56 Commences Phase 56 Clinical Practice Guideline 56 Melphalan 56 Pelvic Floor 56 Colorectal Cancers 56 MRSA Infections 56 Teva Provides Update 56 Suppl 56 Biol Phys 56 Therapeutics Roundtable 56 Molecular Diagnostic 56 Hypertriglyceridemia 56 Immunol 56 Heart Failure Therapies 56 ST Elevation Myocardial